Article
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
AIDS (London, England) - 18 Feb 2000
Welles S L, Pitt J, Colgrove R, McIntosh K, Chung P H, Colson A, Lockman S, Fowler M G, Hanson C, Landesman S, Moye J, Rich K C, Zorrilla C, Japour A J
Abstract excerpt
OBJECTIVES: Although the treatment of pregnant women and their infants with zidovudine (ZDV) has been remarkably effective in preventing the perinatal transmission of human HIV-1, many potentially preventable infections still occur. To examine whether the risk of perinatal infection is increased among women who carry ZDV-resistant HIV-1, the role of genotypic ZDV resistance in perinatal transmission was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
